E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/12/2017 in the Prospect News Preferred Stock Daily.

New Issue: Global Medical REIT prices $67.5 million 7.5% cumulative redeemable preferreds

By Stephanie N. Rotondo

Seattle, Sept. 12 – Global Medical REIT Inc. sold $67.5 million 7.5% series A cumulative redeemable preferred stock at par on Tuesday, the company said in an FWP filed with the Securities and Exchange Commission.

The deal came in line with the 7.5% price talk.

FBR Capital Markets & Co. and Janney Montgomery Scott LLC are the joint bookrunners.

There is a $10,125,000 over-allotment option.

Dividends will be payable on a quarterly basis. The preferreds become redeemable on Sept. 15, 2022 at par plus accrued dividends.

The issue can also be redeemed upon a change of control.

The new securities will be listed on the New York Stock Exchange under the ticker symbol “GMREPrA.”

The Bethesda, Md.-based health care real estate investment trust will contribute proceeds to its operating partnership in exchange for series A cumulative redeemable operating partnership preferred units. The operating partnership will then use proceeds for general corporate purposes, which may include funding new acquisitions and repaying debt.

Issuer:Global Medical REIT Inc.
Securities:Series A cumulative redeemable preferred stock
Amount:$67.5 million, or 2.7 million shares
Greenshoe:$10,125,000, or 405,000 shares
Maturity:Perpetual
Bookrunners:FBR Capital Markets & Co. and Janney Montgomery Scott LLC
Co-managers:BB&T Capital Markets, Compass Point Research & Trading LLC and D.A. Davidson & Co.
Dividend:7.5%
Price:Par of $25.00
Yield:7.5%
Talk:7.5%
Call options:On or after Sept. 15, 2022 or upon a change of control at par plus accrued dividends
Pricing date:Sept. 12
Settlement date:Sept. 15
Expected listing:NYSE: GMREPrA
Cusip:37957W203

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.